Edward practices out of the firm’s New York office, where he prosecutes securities fraud, corporate governance and shareholder rights litigation on behalf of the firm’s institutional clients.
He has been a senior member of the trial teams prosecuting a number of the firm’s most significant recent litigations, including the Allergan Proxy Violation Litigation, in which the team obtained a $250 million settlement for Allergan, Inc. investors after fighting a ferocious three-year legal battle to stop an unprecedented and sophisticated insider-trading scheme by billionaire hedge fund manager Bill Ackman. In recognition of his accomplishments, Edward is regularly included in the list of leading practitioners published by Thomson Reuters’ Super Lawyers, and has been named a "Rising Star" byLaw360. He was recently named to Benchmark Litigation's 2020 "40 and Under Hot List."
Some of his other representative litigations include:
Edward is currently a member of the teams prosecuting In re AmTrust Financial Services, Inc.; Cummings v. Edens (New Senior Investment Group); In re Pilgrim’s Pride; Dieckman v. Regency GP LP; West Palm Beach Firefighters v. Spectrum Brands Holdings, Inc.; In re Straight Path Communications, Inc.; and In re Xerox Corporation.
Prior to joining BLB&G, Edward was a senior litigation associate at a major corporate law firm. Among other matters, he successfully represented corporate clients in complex litigation, including securities class actions, derivative actions, and merger and acquisitions matters.
Edward received his law degree from Columbia Law School in 2009 and bachelor’s degree from Cornell University in 2006, both with academic honors.